Webinar: Transforming Healthcare Systems
Join Octopus, a distinguished group of health tech experts and active family office investors, for a thought-provoking discussion on ‘The role of long
About this event
About this event
The need to create more sustainable healthcare systems that improves patient outcomes, increases efficiency, and ultimately delivers better, more affordable care, for all, has never been greater. As health systems around the world grasp the profound but less publicised consequences of the pandemic, they are rapidly deploying funding into technologies for public and private health systems to ensure they are not as fragile in the future. But we have a long way to go.
Join Octopus, a distinguished group of health tech experts and active family office investors for a thought-provoking discussion on the biggest trends in this sector. Have your questions ready, as our experts dig deep into AI-led advanced diagnostics, precision medicine, and digital therapies.
Event agenda
Event agenda
Hosted by: Joe Stringer (Partner, Octopus Ventures) & Dr Pooja Sikka (Partner, Octopus Ventures)
Chaired by: Paul Reynolds (Chief Executive Officer, Thamesis)
Time
3pm-3.30pm
Keynote presentation (with Q&A)
Speakers: The Rt. Hon. Jeremy Hunt (Chair, Health and Social Care Select Committee)
3.30pm-3.40pm
Industry overview
Speakers: Yoram Wijngaarde (Founder, Dealroom)
3.40pm-4.10pm
Debating the healthcare opportunity set
Join a leading group of health tech entrepreneurs, as they debate the outlook for healthcare. Which sub-sectors are most attractive as we rebuild post-pandemic? Europe and beyond – identifying the geographies that are poised for expansive growth.
Speakers:
- Dr. Mohit Misra, (Co-Founder & CEO , Mango Sciences)
- Hamish Grierson (Chief Executive Officer & Founder, Thriva Health)
- Dr Nadine Hachach-Haram (Founder, Proxmie)
- Tyler Shultz (Chief Executive Officer & Co-Founder, Flux Biosciences)
- David MacMurchy (Chief Executive Officer, Lightship)
Moderated by: Paul Reynolds (Chief Executive Officer, Thamesis)
4.10pm-4.25pm
Why health tech, why now?
Speakers: Joe Stringer (Partner, Octopus Ventures), Dr Pooja Sikka (Partner, Octopus Ventures)
Interviewed by: James Morgon, Managing Director, Milken Institute
4.25pm-4.50pm
Family office investor breakout groups
A chance to exchange ideas with your family office peers, ask our experts questions and dive deeper into a specific area of choice.
- Group 1: Led by Sam Copley (Investment Manager, TruVenturo)
- Group 2: Led by Dr. Shannon Shibata-Germanos (Founder, Lacuna Advisors)
- Group 3: Led by Dr. Sam Roberts (Managing Director, Health & Care, Legal and General)
- Group 4: Led by Paul Reynolds, (Chief Executive, Thamesis)
4.50pm-5pm
Feedback and wrap-up
Speakers
Speakers
Jeremy Hunt
The Rt. Hon. Jeremy Hunt, Chair, Health and Social Care Select Committee
Jeremy Hunt is an authoritative speaker on geopolitics and healthcare. He speaks with enormous experience as one of the most high profile and successful politicians in recent British history, having served in senior Ministerial roles since 2010, under both Prime Minister’s David Cameron and Theresa May. Hunt was the Minister for Culture, Olympics, Media and Sport, responsible for delivering the 2012 London Olympic Games, widely and internationally acclaimed as a resounding success. Promoted to Secretary of State for Health in 2012, he held the post for six years – the longest ever serving Health Secretary, and is credited with far reaching reforms of the National Health Service. As an exceptionally hands-on Minister, he oversaw significant transformation and change within the NHS – the fifth largest employer in the world, and built his keystone policy of “Patient Safety”. He overcame significant challenges in transforming the NHS into a seven day a week organisation, underpinned by the requirement to increase patient safety and prevent unavoidable deaths.
Reappointed as Health Secretary with the additional responsibility of Social Care in 2018, Hunt was responsible for securing an extra £20 Billion of funding for the NHS, shortly before being appointed Secretary of State for Foreign and Commonwealth Affairs. As Foreign Secretary, Hunt was at the forefront of steering the global approach to the UK’s international partners and allies, in the lead up to the UK’s departure from the European Union. He oversaw numerous complex foreign policy affairs, including the strengthening of the US-UK Special Relationship, navigating Britain’s policy in the Middle East and Iran, and forging closer ties with Commonwealth Countries. In January 2020 Hunt was elected as Chair of the Health and Social Care Select Committee. As the UK’s former representative on the world stage, Jeremy Hunt is uniquely placed to comment on Brexit, Globalisation and the World Order as well as the current political and economic climate in the UK. As former Secretary of State for Health, he has exceptional insight into the UK Government and wider global reaction to the 2020 COVID-19 Pandemic. Having previously lived and worked as an entrepreneur in the Far East, Hunt is a fluent Japanese speaker.
Reappointed as Health Secretary with the additional responsibility of Social Care in 2018, Hunt was responsible for securing an extra £20 Billion of funding for the NHS, shortly before being appointed Secretary of State for Foreign and Commonwealth Affairs. As Foreign Secretary, Hunt was at the forefront of steering the global approach to the UK’s international partners and allies, in the lead up to the UK’s departure from the European Union. He oversaw numerous complex foreign policy affairs, including the strengthening of the US-UK Special Relationship, navigating Britain’s policy in the Middle East and Iran, and forging closer ties with Commonwealth Countries. In January 2020 Hunt was elected as Chair of the Health and Social Care Select Committee. As the UK’s former representative on the world stage, Jeremy Hunt is uniquely placed to comment on Brexit, Globalisation and the World Order as well as the current political and economic climate in the UK. As former Secretary of State for Health, he has exceptional insight into the UK Government and wider global reaction to the 2020 COVID-19 Pandemic. Having previously lived and worked as an entrepreneur in the Far East, Hunt is a fluent Japanese speaker.
Yoram Wijngaarde
Founder, Dealroom
Founder of Dealroom.co which was launched in 2014 in Amsterdam to provide insights and intelligence about the world’s most promising companies. Top tier venture capital firms like Sequoia, Balderton, Atomico, and world-class corporates like Google, McKinsey, EY, and others use Dealroom software and data to stay at the forefront of innovation and discover the world’s most promising companies.
Before founding Dealroom, Yoram was an investment banker in New York and London. Yoram has a cum laude Master’s degree in Economics from the University of Amsterdam.
Before founding Dealroom, Yoram was an investment banker in New York and London. Yoram has a cum laude Master’s degree in Economics from the University of Amsterdam.
Joe Stringer
Partner, Octopus Ventures
Joe joined Octopus in 2020 as a co-founder and general partner of TenX Health. He has 25 years’ experience in healthcare, covering technology deployment and management consulting. He founded a number of successful businesses in the sector and subsequently five years of investing.
Prior to joining Octopus, he led Google Health in the UK, and the Ventures and Healthcare practices for EY in the UK. At EY, he was the global healthcare supply chain leader, ran a UK team of 120 healthcare specialists and founded and jointly led three technology businesses in the UK NHS. He has led some of the most significant and high profile transformation programmes – for example a four year / £14bn programme to transform the NHS supply chain.
Prior to joining Octopus, he led Google Health in the UK, and the Ventures and Healthcare practices for EY in the UK. At EY, he was the global healthcare supply chain leader, ran a UK team of 120 healthcare specialists and founded and jointly led three technology businesses in the UK NHS. He has led some of the most significant and high profile transformation programmes – for example a four year / £14bn programme to transform the NHS supply chain.
Dr Pooja Sikka
Partner, Octopus Ventures
Pooja joined Octopus in 2020 as a co-founder and general partner of TenX Health. She continues practising as a GP and has over 16 years’ experience working across the healthcare sector with public and private bodies and NHS providers, leading multiple teams through high profile national and international projects and ventures.
Pooja’s diverse clinical, managerial and entrepreneurial background has put her at the forefront of the changing healthcare landscape in Europe and emerging economies. She is known in the NHS for her health tech expertise and most recently set up a national programme for the NAPC (National Association of Primary Care), to help NHS providers select and roll out health tech products and services. She serves as a council member and clinical advisor to NAPC and, as a founding member of the EY Ventures team, ran the health and social care investment portfolio.
Pooja’s diverse clinical, managerial and entrepreneurial background has put her at the forefront of the changing healthcare landscape in Europe and emerging economies. She is known in the NHS for her health tech expertise and most recently set up a national programme for the NAPC (National Association of Primary Care), to help NHS providers select and roll out health tech products and services. She serves as a council member and clinical advisor to NAPC and, as a founding member of the EY Ventures team, ran the health and social care investment portfolio.
Dr. Shannon Shibata-Germanos
Founder, Lacuna Advisors
Shannon Shibata-Germanos runs her family office focusing on health tech investments and is a global health advisor. As an investor, her main thematic areas of interest are health-tech, biotech, med-tech, frugal innovation, and personalized medicine. A sampling of health-tech specific companies from her portfolio include companies such as CuriBio, Ceevra, Ilara Health, Proximie, UhOh Labs and iamYiam. With two decades of experience in political policy analysis, conflict management, and institutional development in the Middle East and Sub Saharan Africa, Shannon has advised heads of state, royal families and CEOs in complex policy and business negotiations.
One of her areas of special focus is SDG3 and global public health policy, especially building private-public partnership ecosystems (including policy makers and government agencies) around commercial startups with unique medical technologies that have the capacity to make quality healthcare more accessible and equitable worldwide. Along with her professional responsibilities, Shannon also remains a visiting Dementia researcher at University College London, and sits on the International Boards of the UNAIDS Health Innovation Exchange, Global Bio Fund, and The Digital Inclusion Foundation. She holds a PhD in Neuroscience from University College London.
One of her areas of special focus is SDG3 and global public health policy, especially building private-public partnership ecosystems (including policy makers and government agencies) around commercial startups with unique medical technologies that have the capacity to make quality healthcare more accessible and equitable worldwide. Along with her professional responsibilities, Shannon also remains a visiting Dementia researcher at University College London, and sits on the International Boards of the UNAIDS Health Innovation Exchange, Global Bio Fund, and The Digital Inclusion Foundation. She holds a PhD in Neuroscience from University College London.
Dr Sam Roberts
Managing Director, Health & Care, Legal and General
Dr. Sam Roberts is the Managing Director of Health and Care at Legal and General, focusing on our investment strategy across the health and care sector within L&G’s Capital and Retail Retirement businesses.
Prior to this Sam was Chief Executive of the Accelerated Access Collaborative, the national umbrella organisation for health innovation, hosted in NHS England and NHS Improvement. Sam has worked in healthcare for almost 20 years, originally as a doctor before undertaking an MBA and joining McKinsey and Company, followed by a number of senior roles in the NHS.
She has a research interest in using health economic models to inform health policy and commissioning and completed a DPhil in Evidence Based Medicine at the University of Oxford on this topic.
Prior to this Sam was Chief Executive of the Accelerated Access Collaborative, the national umbrella organisation for health innovation, hosted in NHS England and NHS Improvement. Sam has worked in healthcare for almost 20 years, originally as a doctor before undertaking an MBA and joining McKinsey and Company, followed by a number of senior roles in the NHS.
She has a research interest in using health economic models to inform health policy and commissioning and completed a DPhil in Evidence Based Medicine at the University of Oxford on this topic.
Sam Copley
Investment Manager, TruVenturo
Sam Copley is investment manager for TruVenturo, a single family office focusing on venture capital in tech and the life sciences. Before this role, Sam was associate director at Euromoney Institutional Investor (EII), where he helped run a fund-manager search service that placed USD 12.6 billion. Sam previously worked in political risk throughout Asia-Pacific and was educated at Oxford, in London and Tokyo.
Mohit Misra
Co-Founder & CEO , Mango Sciences
Mohit is a physician, trained health economist, ex-strategy consultant and most recently an investor, who has extensive global experience across the healthcare landscape with specific expertise at the intersection of data, technology and healthcare.
At Mango Sciences, our mission is to make cancer care more accessible and affordable for people across the developing world. With 2.3M newly diagnosed cancer patients across Asia every year, the vast majority are unable to afford life saving targeted immunotherapies which are standard of care in the developed world. We solve this problem by bringing the ecosystem of hospitals, life sciences and lenders together to enable risk-based financing for these life saving drugs. Patients pay for clinical outcomes which is made affordable by microfinancing.Mango Sciences believes everyone across the globe should have access to life saving innovation.
At Mango Sciences, our mission is to make cancer care more accessible and affordable for people across the developing world. With 2.3M newly diagnosed cancer patients across Asia every year, the vast majority are unable to afford life saving targeted immunotherapies which are standard of care in the developed world. We solve this problem by bringing the ecosystem of hospitals, life sciences and lenders together to enable risk-based financing for these life saving drugs. Patients pay for clinical outcomes which is made affordable by microfinancing.Mango Sciences believes everyone across the globe should have access to life saving innovation.
Hamish Grierson
Chief Executive Officer & Founder, Thriva Health
Hamish Grierson is CEO of proactive health company, Thriva, which he set up in 2015 with co-founders, Eliot Brooks and Tom Livesey, with a mission to put better health in anyone’s hands. At Thriva, he combined his interest with health and bio-hacking with his experience in technology and innovation. A serial entrepreneur and alumni of the New Entrepreneurs Foundation, Hamish has a background in Fintech innovation, brand building and international growth. Through affordable, clinical-grade testing, coaching and advice based on the latest research, Thriva has now helped over 850,000 people across the UK proactively manage their own health.
Paul Reynolds
Chief Executive, Thamesis Limited
Paul Reynolds is the Chief Executive of Thamesis Limited, a single-family office looking after the first and second generation of a British family. In addition, he acts as an adviser to families and individuals who require a partner for navigating the complex multi-dimensional world of wealth management and generational planning.
Paul has over 30 years’ banking and investment experience looking after families and ultra-high net worth individuals. During this time, he has worked for two single family offices, a multi-family office and has also spent nine years at Credit Suisse. He speaks regularly at Family Office Conferences around the world. Paul is a fellow of the Chartered Institute for Securities & Investment. He is Chair of Trustees of Bowel Research UK and a Trustee of the River & Rowing Museum in Henley.
Paul has over 30 years’ banking and investment experience looking after families and ultra-high net worth individuals. During this time, he has worked for two single family offices, a multi-family office and has also spent nine years at Credit Suisse. He speaks regularly at Family Office Conferences around the world. Paul is a fellow of the Chartered Institute for Securities & Investment. He is Chair of Trustees of Bowel Research UK and a Trustee of the River & Rowing Museum in Henley.